Medications

Zurampic approved for gout

(HealthDay)—Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

Dec 23, 2015
popularity1 comments 0

Towards the rational use of medicines

Rational use of medicines is one of the most challenging problems in health systems worldwide. Kazan Federal University researchers conducted a practical study to assess the impact of introducing evidence-based principles ...

Dec 23, 2015
popularity1 comments 0

Opioid dependency peaks among younger age group

A Michigan State University study shows that 14- and 15-year-olds are at a higher risk of becoming dependent on prescription drugs within a 12-month period after using them extra-medically, or beyond the prescribed amount.

Dec 22, 2015
popularity2 comments 0

Uptravi approved for chronic lung disease

(HealthDay)—Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a disabling lung disease that often leads to death or the need for lung transplant.

Dec 22, 2015
popularity1 comments 0

Evolocumab: No hint of added benefit

Evolocumab (trade name: Repatha) has been approved since July 2015 for two therapeutic indications: on the one hand, for hypercholesterolaemia or mixed dyslipidaemia, and on the other, for homozygous familial hypercholesterolaemia. ...

Dec 22, 2015
popularity0 comments 0